ArticleOccupational and environmental medicine2026
Systemic chronic beryllium disease: beyond lung disease.
Article in Occupational and environmental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSystemic involvement in chronic beryllium disease (CBD) has been reported only anecdotally.
methodsWe describe a case series of six patients with CBD demonstrating systemic involvement across diverse occupational settings.
resultsAll patients had documented occupational beryllium exposure. CBD diagnosis was confirmed by positive histology and lymphocyte proliferation test in all cases. All patients presented with signs of extrapulmonary organ involvement, including hepatic, gastric, neurologic, splenic, ocular, cutaneous, as well as possible cardiac and renal involvement.
conclusionsThis series underscores the importance of including CBD in the differential diagnosis of sarcoidosis in workers with possible beryllium exposure, even in the presence of extrapulmonary manifestations. Clinicians should maintain awareness of extrapulmonary involvement in patients with CBD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.